- Home
- BRLT vs SLGL Comparison
BRLT vs SLGL Comparison
Compare BRLT & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- SLGL
- Stock Information
- Founded
- BRLT 2005
- SLGL 1997
- Country
- BRLT United States
- SLGL Israel
- Employees
- BRLT N/A
- SLGL N/A
- Industry
- BRLT Consumer Specialties
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- BRLT Consumer Discretionary
- SLGL Health Care
- Exchange
- BRLT Nasdaq
- SLGL Nasdaq
- Market Cap
- BRLT 21.8M
- SLGL 19.3M
- IPO Year
- BRLT 2021
- SLGL 2018
- Fundamental
- Price
- BRLT $1.38
- SLGL $7.26
- Analyst Decision
- BRLT Hold
- SLGL Buy
- Analyst Count
- BRLT 3
- SLGL 1
- Target Price
- BRLT $1.80
- SLGL $40.00
- AVG Volume (30 Days)
- BRLT 54.4K
- SLGL 25.5K
- Earning Date
- BRLT 08-07-2025
- SLGL 08-15-2025
- Dividend Yield
- BRLT N/A
- SLGL N/A
- EPS Growth
- BRLT N/A
- SLGL N/A
- EPS
- BRLT N/A
- SLGL N/A
- Revenue
- BRLT $418,708,000.00
- SLGL $12,103,000.00
- Revenue This Year
- BRLT $3.79
- SLGL N/A
- Revenue Next Year
- BRLT $3.85
- SLGL $31.17
- P/E Ratio
- BRLT N/A
- SLGL N/A
- Revenue Growth
- BRLT N/A
- SLGL 603.66
- 52 Week Low
- BRLT $1.25
- SLGL $3.34
- 52 Week High
- BRLT $2.68
- SLGL $16.50
- Technical
- Relative Strength Index (RSI)
- BRLT 49.19
- SLGL 52.97
- Support Level
- BRLT $1.32
- SLGL $7.02
- Resistance Level
- BRLT $1.40
- SLGL $7.58
- Average True Range (ATR)
- BRLT 0.05
- SLGL 0.37
- MACD
- BRLT 0.00
- SLGL 0.02
- Stochastic Oscillator
- BRLT 50.00
- SLGL 41.28
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.